3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma
2
Leukemia
2
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, T-Cell
1
Leukemia, Lymphoid
1
Burkitt Lymphoma
1
Interventions
Dexamethasone
8
Cytarabine
7
Cyclophosphamide
7
venetoclax
6
Vincristine
6
Methotrexate
5
merphos
4
Rituximab
4
Prednisone
4
pegaspargase
3
fludarabine phosphate
3
dexamethasone acetate
3
dexamethasone 21-phosphate
3
Peripheral Blood Stem Cell Transplantation
3
Filgrastim
3
Calcium Dobesilate
3
ruxolitinib
2
prednylidene
2
nelarabine
2
deltacortene
2
auricularum
2
Whole-Body Irradiation
2
Specimen Handling
2
Pentetic Acid
2
Mycophenolic Acid
2
Injections
2
Granulocyte Colony-Stimulating Factor
2
Everolimus
2
Etoposide
2
Decitabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
forodesine
×
Clear all
NCT00742495
2012-10-24
BCX1777-108
Mundipharma Research Limited
Phase 1/2
Terminated
2 enrolled